Publication | Open Access
Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant Melanoma
43
Citations
33
References
2016
Year
The described results provide a strong rationale for the clinical trials implemented in BRAF(V600E) melanoma patients with BRAF-I and IFNα combination.
| Year | Citations | |
|---|---|---|
Page 1
Page 1